These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 29472310)

  • 41. Post-chemoradiation volumetric response predicts survival in newly diagnosed glioblastoma treated with radiation, temozolomide, and bevacizumab or placebo.
    Ellingson BM; Abrey LE; Garcia J; Chinot O; Wick W; Saran F; Nishikawa R; Henriksson R; Mason WP; Harris RJ; Leu K; Woodworth DC; Mehta A; Raymond C; Chakhoyan A; Pope WB; Cloughesy TF
    Neuro Oncol; 2018 Oct; 20(11):1525-1535. PubMed ID: 29897562
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quality of Life Perception, Cognitive Function, and Psychological Status in a Real-world Population of Glioblastoma Patients Treated With Radiotherapy and Temozolomide: A Single-center Prospective Study.
    Lombardi G; Bergo E; Del Bianco P; Bellu L; Pambuku A; Caccese M; Trentin L; Zagonel V
    Am J Clin Oncol; 2018 Dec; 41(12):1263-1271. PubMed ID: 29750673
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interim Results of a Phase II Study of Hypofractionated Radiotherapy with Concurrent Temozolomide Followed by Adjuvant Temozolomide in Patients over 70 Years Old with Newly Diagnosed Glioblastoma.
    Yusuf M; Ugiliweneza B; Amsbaugh M; Boakye M; Williams B; Nelson M; Hattab EM; Woo S; Burton E
    Oncology; 2018; 95(1):39-42. PubMed ID: 29694955
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with glioblastoma: the randomized, open-label, phase II ARTE trial.
    Wirsching HG; Tabatabai G; Roelcke U; Hottinger AF; Jörger F; Schmid A; Plasswilm L; Schrimpf D; Mancao C; Capper D; Conen K; Hundsberger T; Caparrotti F; von Moos R; Riklin C; Felsberg J; Roth P; Jones DTW; Pfister S; Rushing EJ; Abrey L; Reifenberger G; Held L; von Deimling A; Ochsenbein A; Weller M
    Ann Oncol; 2018 Jun; 29(6):1423-1430. PubMed ID: 29648580
    [TBL] [Abstract][Full Text] [Related]  

  • 45. JCOG0911 INTEGRA study: a randomized screening phase II trial of interferonβ plus temozolomide in comparison with temozolomide alone for newly diagnosed glioblastoma.
    Wakabayashi T; Natsume A; Mizusawa J; Katayama H; Fukuda H; Sumi M; Nishikawa R; Narita Y; Muragaki Y; Maruyama T; Ito T; Beppu T; Nakamura H; Kayama T; Sato S; Nagane M; Mishima K; Nakasu Y; Kurisu K; Yamasaki F; Sugiyama K; Onishi T; Iwadate Y; Terasaki M; Kobayashi H; Matsumura A; Ishikawa E; Sasaki H; Mukasa A; Matsuo T; Hirano H; Kumabe T; Shinoura N; Hashimoto N; Aoki T; Asai A; Abe T; Yoshino A; Arakawa Y; Asano K; Yoshimoto K; Shibui S;
    J Neurooncol; 2018 Jul; 138(3):627-636. PubMed ID: 29557060
    [TBL] [Abstract][Full Text] [Related]  

  • 46. SEER-based risk stratification system for patients with primary non-cirrhotic liver cancer.
    Cao R; Jiang H; Liang G; Zhang W
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):12033-12045. PubMed ID: 37421456
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A novel risk signature for predicting brain metastasis in patients with lung adenocarcinoma.
    Zhao Y; Gu S; Li L; Zhao R; Xie S; Zhang J; Zhou R; Tu L; Jiang L; Zhang S; Ma S
    Neuro Oncol; 2023 Dec; 25(12):2207-2220. PubMed ID: 37379245
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Surgeon experience in glioblastoma surgery of the elderly-a multicenter, retrospective cohort study.
    Pöppe JP; Machegger L; Steinbacher J; Stefanits H; Eisschiel S; Gruber A; Demetz M; Ladisich B; Kraus TFJ; Weis S; Spiegl-Kreinecker S; Romagna A; Griessenauer CJ; Jahromi BR; Rautalin I; Niemelä M; Korja M; Schwartz C
    J Neurooncol; 2023 Feb; 161(3):563-572. PubMed ID: 36719614
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of maximal extent of resection on postoperative deficits, patient functioning, and survival within clinically important glioblastoma subgroups.
    Gerritsen JKW; Zwarthoed RH; Kilgallon JL; Nawabi NL; Versyck G; Jessurun CAC; Pruijn KP; Fisher FL; Larivière E; Solie L; Mekary RA; Satoer DD; Schouten JW; Bos EM; Kloet A; Tewarie RN; Smith TR; Dirven CMF; De Vleeschouwer S; Vincent AJPE; Broekman MLD
    Neuro Oncol; 2023 May; 25(5):958-972. PubMed ID: 36420703
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effectiveness of different treatment strategies in elderly patients with glioblastoma: An evidence map of randomized controlled trials.
    Ma W; Sheng X; Li G; Wei Q; Zhou Z; Qiu X
    Crit Rev Oncol Hematol; 2022 May; 173():103645. PubMed ID: 35227898
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Surgical strategies for older patients with glioblastoma.
    Barak T; Vetsa S; Nadar A; Jin L; Gupte TP; Fomchenko EI; Miyagishima DF; Yalcin K; Vasandani S; Gorelick E; Zhao AY; Antonios J; Theriault BC; Lifton N; Marianayagam N; Omay B; Omay ZE; Huttner A; McGuone D; Blondin NA; Corbin Z; Fulbright RK; Moliterno J
    J Neurooncol; 2021 Dec; 155(3):255-264. PubMed ID: 34626296
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014-2018.
    Ostrom QT; Cioffi G; Waite K; Kruchko C; Barnholtz-Sloan JS
    Neuro Oncol; 2021 Oct; 23(12 Suppl 2):iii1-iii105. PubMed ID: 34608945
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Competing risk model to determine the prognostic factors and treatment strategies for elderly patients with glioblastoma.
    Liu ZY; Feng SS; Zhang YH; Zhang LY; Xu SC; Li J; Cao H; Huang J; Fan F; Cheng L; Jiang JY; Cheng Q; Liu ZX
    Sci Rep; 2021 Apr; 11(1):9321. PubMed ID: 33927308
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Real-world evaluation of the impact of radiotherapy and chemotherapy in elderly patients with glioblastoma based on age and performance status.
    Al Feghali KA; Buszek SM; Elhalawani H; Chevli N; Allen PK; Chung C
    Neurooncol Pract; 2021 Apr; 8(2):199-208. PubMed ID: 33898053
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lack of survival advantage among re-resected elderly glioblastoma patients: a SEER-Medicare study.
    Goldman DA; Reiner AS; Diamond EL; DeAngelis LM; Tabar V; Panageas KS
    Neurooncol Adv; 2021; 3(1):vdaa159. PubMed ID: 33506202
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A prognostic nomogram for patients with newly diagnosed adult thalamic glioma in a surgical cohort.
    Niu X; Yang Y; Zhou X; Zhang H; Zhang Y; Liu Y; Mao Q
    Neuro Oncol; 2021 Feb; 23(2):337-338. PubMed ID: 33244611
    [No Abstract]   [Full Text] [Related]  

  • 57. Performance of a nomogram for IDH-wild-type glioblastoma patient survival in an elderly cohort.
    Shen E; Johnson MO; Lee JW; Lipp ES; Randazzo DM; Desjardins A; McLendon RE; Friedman HS; Ashley DM; Kirkpatrick JP; Peters KB; Walsh KM
    Neurooncol Adv; 2019; 1(1):vdz036. PubMed ID: 32642665
    [No Abstract]   [Full Text] [Related]  

  • 58. Survival Risk Prediction Models of Gliomas Based on IDH and 1p/19q.
    Zou H; Li C; Wanggou S; Li X
    J Cancer; 2020; 11(15):4297-4307. PubMed ID: 32489448
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Surgical treatment and survival outcome of patients with adult thalamic glioma: a single institution experience of 8 years.
    Niu X; Wang T; Zhou X; Yang Y; Wang X; Zhang H; Chen N; Yue Q; Wang F; Zhang Y; Liu Y; Mao Q
    J Neurooncol; 2020 Apr; 147(2):377-386. PubMed ID: 32157551
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association of Maximal Extent of Resection of Contrast-Enhanced and Non-Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed Glioblastoma.
    Molinaro AM; Hervey-Jumper S; Morshed RA; Young J; Han SJ; Chunduru P; Zhang Y; Phillips JJ; Shai A; Lafontaine M; Crane J; Chandra A; Flanigan P; Jahangiri A; Cioffi G; Ostrom Q; Anderson JE; Badve C; Barnholtz-Sloan J; Sloan AE; Erickson BJ; Decker PA; Kosel ML; LaChance D; Eckel-Passow J; Jenkins R; Villanueva-Meyer J; Rice T; Wrensch M; Wiencke JK; Oberheim Bush NA; Taylor J; Butowski N; Prados M; Clarke J; Chang S; Chang E; Aghi M; Theodosopoulos P; McDermott M; Berger MS
    JAMA Oncol; 2020 Apr; 6(4):495-503. PubMed ID: 32027343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.